应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
VOR Vor Biopharma Inc.
交易中 03-02 15:15:00 EST
15.91
+0.47
+3.01%
最高
16.11
最低
14.98
成交量
67.87万
今开
15.00
昨收
15.44
日振幅
7.32%
总市值
6.60亿
流通市值
3.02亿
总股本
4,152万
成交额
1,048万
换手率
3.58%
流通股本
1,897万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Vor Biopharma Inc. - 股东拟转售1390万股普通股之招股说明书 - 美国证监会文件披露
美股速递 · 01-30
Vor Biopharma Inc. - 股东拟转售1390万股普通股之招股说明书 - 美国证监会文件披露
Vor Biopharma Inc.任命Ra Capital的Andrew Levin医学博士及Forbion的Wouter Joustra为董事会成员
美股速递 · 2025-12-24
Vor Biopharma Inc.任命Ra Capital的Andrew Levin医学博士及Forbion的Wouter Joustra为董事会成员
Vor Biopharma Inc. - 在对成人IgA肾病评估Telitacicept的三期临床研究A阶段中达到主要终点
美股速递 · 2025-11-09
Vor Biopharma Inc. - 在对成人IgA肾病评估Telitacicept的三期临床研究A阶段中达到主要终点
Telitacicept在48周中国III期开放标签扩展试验中显示持续疗效及良好安全性
美股速递 · 2025-10-29
Telitacicept在48周中国III期开放标签扩展试验中显示持续疗效及良好安全性
修正-Vor Biopharma Inc. : H.c. Wainwright 将目标价提高至 $55(不是 $52),基于 1拆20 股票回购(澄清目标价已调整)
美股速递 · 2025-10-29
修正-Vor Biopharma Inc. : H.c. Wainwright 将目标价提高至 $55(不是 $52),基于 1拆20 股票回购(澄清目标价已调整)
Vor Biopharma Inc向SEC提交文件,由现有股东出售最多5100万股普通股
美股速递 · 2025-09-25
Vor Biopharma Inc向SEC提交文件,由现有股东出售最多5100万股普通股
Vor Biopharma Inc.:Stifel将评级从持有上调至买入,目标价从0.3美元上调至55美元以反映股票分割
美股速递 · 2025-09-24
Vor Biopharma Inc.:Stifel将评级从持有上调至买入,目标价从0.3美元上调至55美元以反映股票分割
Vor Bio宣布将在AANEM会议上口头汇报48周中国三期全身性重症肌无力临床研究结果
美股速递 · 2025-09-18
Vor Bio宣布将在AANEM会议上口头汇报48周中国三期全身性重症肌无力临床研究结果
Vor Biopharma Inc.盘中异动 下午盘股价大跌5.00%
市场透视 · 2025-09-05
Vor Biopharma Inc.盘中异动 下午盘股价大跌5.00%
Vor Biopharma Inc.盘中异动 急速下挫5.00%报0.950美元
市场透视 · 2025-03-10
Vor Biopharma Inc.盘中异动 急速下挫5.00%报0.950美元
Vor Biopharma Inc.盘中异动 早盘股价大跌5.46%报0.900美元
市场透视 · 2025-03-04
Vor Biopharma Inc.盘中异动 早盘股价大跌5.46%报0.900美元
Vor Biopharma Inc.盘中异动 早盘股价大跌14.32%报0.951美元
市场透视 · 2025-02-28
Vor Biopharma Inc.盘中异动 早盘股价大跌14.32%报0.951美元
Vor Biopharma Inc.盘中异动 急速下挫5.55%报1.19美元
市场透视 · 2025-02-27
Vor Biopharma Inc.盘中异动 急速下挫5.55%报1.19美元
Vor Biopharma Inc.盘中异动 早盘大幅下挫5.30%
市场透视 · 2025-02-26
Vor Biopharma Inc.盘中异动 早盘大幅下挫5.30%
Vor Biopharma Inc.盘中异动 股价大涨5.47%报1.45美元
市场透视 · 2025-02-18
Vor Biopharma Inc.盘中异动 股价大涨5.47%报1.45美元
Vor Biopharma Inc.盘中异动 早盘大幅下跌5.07%
市场透视 · 2025-02-13
Vor Biopharma Inc.盘中异动 早盘大幅下跌5.07%
Vor Biopharma Inc.盘中异动 股价大跌5.07%
市场透视 · 2025-02-11
Vor Biopharma Inc.盘中异动 股价大跌5.07%
Vor Biopharma Inc.盘中异动 早盘快速下挫6.38%
市场透视 · 2025-02-10
Vor Biopharma Inc.盘中异动 早盘快速下挫6.38%
Vor Biopharma Inc.盘中异动 股价大跌6.00%
市场透视 · 2025-02-08
Vor Biopharma Inc.盘中异动 股价大跌6.00%
Vor Biopharma Inc.盘中异动 临近午盘急速拉升5.40%报1.47美元
市场透视 · 2025-02-06
Vor Biopharma Inc.盘中异动 临近午盘急速拉升5.40%报1.47美元
加载更多
公司概况
公司名称:
Vor Biopharma Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Vor Biopharma Inc.于2015年12月30日在特拉华州注册成立为PureTech Health LLC的全资子公司。该公司是一家临床阶段的细胞疗法公司,结合了新颖的患者工程方法和靶向疗法,为患有血液系统恶性肿瘤的患者提供了单一的公司解决方案。该公司的专有平台利用其在造血干细胞生物学,基因组工程和靶向疗法开发方面的专业知识,对HSC进行基因修饰,以去除癌细胞表达的表面靶标。Vor总部位于马萨诸塞州剑桥。
发行价格:
--
{"stockData":{"symbol":"VOR","market":"US","secType":"STK","nameCN":"Vor Biopharma Inc.","latestPrice":15.905,"timestamp":1772482495029,"preClose":15.44,"halted":0,"volume":678670,"delay":0,"changeRate":0.03011658031088082,"floatShares":18971400,"shares":41519800,"eps":-386.86,"marketStatus":"交易中","change":0.465,"latestTime":"03-02 15:15:00 EST","open":15,"high":16.11,"low":14.98,"amount":10477014.27456,"amplitude":0.073187,"askPrice":15.96,"askSize":312,"bidPrice":15.86,"bidSize":64,"shortable":3,"etf":0,"ttmEps":-386.86,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1772485200000},"marketStatusCode":2,"adr":0,"listingDate":1612501200000,"exchange":"NASDAQ","adjPreClose":15.44,"preHourTrading":{"tag":"盘前","latestPrice":14.71,"preClose":15.44,"latestTime":"09:27 EST","volume":2520,"amount":38177.85888,"timestamp":1772461670016,"change":-0.73,"changeRate":-0.04728,"amplitude":0.046632},"postHourTrading":{"tag":"盘后","latestPrice":15.55,"preClose":15.44,"latestTime":"19:21 EST","volume":9226,"amount":143329.43,"timestamp":1772238072593,"change":0.11,"changeRate":0.007124,"amplitude":0.007124},"volumeRatio":0.919637,"impliedVol":1.3167,"impliedVolPercentile":0.4786},"requestUrl":"/m/hq/s/VOR","defaultTab":"news","newsList":[{"id":"1121110994","title":"Vor Biopharma Inc. - 股东拟转售1390万股普通股之招股说明书 - 美国证监会文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1121110994","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1121110994?lang=zh_cn&edition=full","pubTime":"2026-01-30 05:17","pubTimestamp":1769721459,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会(SEC)最新披露的文件显示,生物制药公司Vor Biopharma Inc.已提交招股说明书,其现有股东计划公开转售1390万股公司普通股。\n此次股份转售涉及多位售股股东,相关文件已按监管要求完成备案程序。招股说明书中详细列明了股份转售的具体条款、股东信息及潜在风险因素等内容。\n该文件的公布为市场提供了公司股权结构变动的重要参考依据,投资者可据此评估流通股数量增加对股价的潜在影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VOR"],"gpt_icon":0},{"id":"1175976028","title":"Vor Biopharma Inc.任命Ra Capital的Andrew Levin医学博士及Forbion的Wouter Joustra为董事会成员","url":"https://stock-news.laohu8.com/highlight/detail?id=1175976028","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175976028?lang=zh_cn&edition=full","pubTime":"2025-12-24 05:02","pubTimestamp":1766523775,"startTime":"0","endTime":"0","summary":"Vor Biopharma Inc.任命Ra Capital的Andrew Levin医学博士及Forbion的Wouter Joustra为董事会成员","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VOR","BK4139"],"gpt_icon":0},{"id":"1172598054","title":"Vor Biopharma Inc. - 在对成人IgA肾病评估Telitacicept的三期临床研究A阶段中达到主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=1172598054","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172598054?lang=zh_cn&edition=full","pubTime":"2025-11-09 00:48","pubTimestamp":1762620491,"startTime":"0","endTime":"0","summary":"Vor Biopharma Inc. - 在对成人IgA肾病评估Telitacicept的三期临床研究A阶段中达到主要终点","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VOR"],"gpt_icon":0},{"id":"1161096783","title":"Telitacicept在48周中国III期开放标签扩展试验中显示持续疗效及良好安全性","url":"https://stock-news.laohu8.com/highlight/detail?id=1161096783","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161096783?lang=zh_cn&edition=full","pubTime":"2025-10-29 23:02","pubTimestamp":1761750130,"startTime":"0","endTime":"0","summary":"Telitacicept在48周中国III期开放标签扩展试验中显示持续疗效及良好安全性","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VOR"],"gpt_icon":0},{"id":"1108854682","title":"修正-Vor Biopharma Inc. : H.c. Wainwright 将目标价提高至 $55(不是 $52),基于 1拆20 股票回购(澄清目标价已调整)","url":"https://stock-news.laohu8.com/highlight/detail?id=1108854682","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108854682?lang=zh_cn&edition=full","pubTime":"2025-10-29 20:54","pubTimestamp":1761742459,"startTime":"0","endTime":"0","summary":"修正-Vor Biopharma Inc. : H.c. Wainwright 将目标价提高至 $55(不是 $52),基于 1拆20 股票回购(澄清目标价已调整)","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VOR"],"gpt_icon":0},{"id":"1167290647","title":"Vor Biopharma Inc向SEC提交文件,由现有股东出售最多5100万股普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1167290647","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167290647?lang=zh_cn&edition=full","pubTime":"2025-09-25 05:00","pubTimestamp":1758747618,"startTime":"0","endTime":"0","summary":"根据向美国证券交易委员会(SEC)提交的文件显示,Vor Biopharma Inc已提交相关申请,计划由现有股东出售最多5100万股普通股。\n此次股票发售并非由公司直接进行,而是由现有股东通过二级市场出售其持有的股份。该公司已向SEC提交了相应的监管文件,为此次股票出售做好准备工作。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VOR","BK4139"],"gpt_icon":0},{"id":"1122383513","title":"Vor Biopharma Inc.:Stifel将评级从持有上调至买入,目标价从0.3美元上调至55美元以反映股票分割","url":"https://stock-news.laohu8.com/highlight/detail?id=1122383513","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122383513?lang=zh_cn&edition=full","pubTime":"2025-09-24 18:35","pubTimestamp":1758710125,"startTime":"0","endTime":"0","summary":"Vor Biopharma Inc.:Stifel将评级从持有上调至买入,目标价从0.3美元上调至55美元以反映股票分割","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VOR"],"gpt_icon":0},{"id":"1161288797","title":"Vor Bio宣布将在AANEM会议上口头汇报48周中国三期全身性重症肌无力临床研究结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1161288797","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161288797?lang=zh_cn&edition=full","pubTime":"2025-09-18 04:16","pubTimestamp":1758140175,"startTime":"0","endTime":"0","summary":"Vor Bio宣布将在AANEM会议上口头汇报48周中国三期全身性重症肌无力临床研究结果","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VOR","BK4139"],"gpt_icon":0},{"id":"2565258257","title":"Vor Biopharma Inc.盘中异动 下午盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2565258257","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565258257?lang=zh_cn&edition=full","pubTime":"2025-09-05 03:24","pubTimestamp":1757013893,"startTime":"0","endTime":"0","summary":"北京时间2025年09月05日03时24分,Vor Biopharma Inc.股票出现异动,股价快速跳水5.00%。截至发稿,该股报1.90美元/股,成交量365.814万股,换手率2.89%,振幅4.75%。Vor Biopharma Inc.股票所在的生物技术行业中,整体涨幅为0.10%。其相关个股中,Novabay Pharmaceuticals, Inc.、Apollomics Inc C/Wts 01/04/2028 、Lexaria Bioscience Corp C/Wts 14/01/2026 涨幅较大,Purple Biotech Ltd、Novabay Pharmaceuticals, Inc.、Soligenix, Inc.较为活跃,换手率分别为1736.20%、282.54%、147.06%,振幅较大的相关个股有Novabay Pharmaceuticals, Inc.、Apollomics Inc C/Wts 01/04/2028 、Psyence Biomedical Ltd C/Wts 25/01/2029,振幅分别为62.31%、51.55%、51.23%。Vor Biopharma Inc.公司简介:Vor Biopharma Inc是一家临床阶段细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250905032453a710272b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250905032453a710272b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VOR"],"gpt_icon":0},{"id":"2518806279","title":"Vor Biopharma Inc.盘中异动 急速下挫5.00%报0.950美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518806279","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518806279?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:22","pubTimestamp":1741616539,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时22分,Vor Biopharma Inc.股票出现波动,股价大幅下挫5.00%。截至发稿,该股报0.950美元/股,成交量1.0984万股,换手率0.01%,振幅7.99%。Vor Biopharma Inc.股票所在的生物技术行业中,整体涨幅为0.47%。其相关个股中,Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Aeon Biopharma, Inc.涨幅较大,Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃,换手率分别为3400.89%、719.71%、414.19%,振幅较大的相关个股有Dogwood Therapeutics, Inc.、Scisparc Ltd.、Biodexa Pharmaceuticals Plc,振幅分别为41.36%、40.24%、39.34%。Vor Biopharma Inc.公司简介:Vor Biopharma Inc 是一家处于临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310222219abf30f41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310222219abf30f41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VOR","BK4139"],"gpt_icon":0},{"id":"2516608852","title":"Vor Biopharma Inc.盘中异动 早盘股价大跌5.46%报0.900美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516608852","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516608852?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:35","pubTimestamp":1741098917,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时35分,Vor Biopharma Inc.股票出现波动,股价快速下挫5.46%。截至发稿,该股报0.900美元/股,成交量5.9896万股,换手率0.05%,振幅6.10%。Vor Biopharma Inc.股票所在的生物技术行业中,整体涨幅为0.11%。其相关个股中,Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Protagenic Therapeutics, Inc.、Exicure, Inc.涨幅较大,Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃,换手率分别为1076.47%、1070.68%、423.99%,振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Adma Biologics Inc、Ibio, Inc.,振幅分别为23.30%、12.57%、12.01%。Vor Biopharma Inc.公司简介:Vor Biopharma Inc 是一家处于临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223517963945c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223517963945c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VOR","BK4139"],"gpt_icon":0},{"id":"2514781403","title":"Vor Biopharma Inc.盘中异动 早盘股价大跌14.32%报0.951美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514781403","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514781403?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:31","pubTimestamp":1740753064,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时31分,Vor Biopharma Inc.股票出现异动,股价急速下跌14.32%。截至发稿,该股报0.951美元/股,成交量3.5882万股,换手率0.03%,振幅5.32%。Vor Biopharma Inc.股票所在的生物技术行业中,整体涨幅为0.02%。其相关个股中,Tc Biopharm Plc C/Wts 10/02/2028 、Anaptysbio, Inc.、Enveric Biosciences, Inc.涨幅较大,Bioxcel Therapeutics, Inc.、Virpax Pharmaceuticals, Inc.、Enveric Biosciences, Inc.较为活跃,换手率分别为480.24%、239.11%、55.69%,振幅较大的相关个股有Trevi Therapeutics, Inc.、Enanta Pharmaceuticals, Inc.、Aardvark Therapeutics, Inc.,振幅分别为7.11%、6.58%、6.22%。Vor Biopharma Inc.公司简介:Vor Biopharma Inc 是一家处于临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223104a25800bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223104a25800bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VOR"],"gpt_icon":0},{"id":"2514626948","title":"Vor Biopharma Inc.盘中异动 急速下挫5.55%报1.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514626948","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514626948?lang=zh_cn&edition=full","pubTime":"2025-02-27 04:21","pubTimestamp":1740601275,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日04时21分,Vor Biopharma Inc.股票出现波动,股价快速下挫5.55%。截至发稿,该股报1.19美元/股,成交量17.4441万股,换手率0.14%,振幅5.56%。Vor Biopharma Inc.股票所在的生物技术行业中,整体跌幅为0.69%。其相关个股中,Enveric Biosciences, Inc.、Renovaro Inc.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大,Enveric Biosciences, Inc.、Aeon Biopharma, Inc.、Organovo Holdings, Inc.较为活跃,换手率分别为6817.48%、325.68%、264.02%,振幅较大的相关个股有Enveric Biosciences, Inc.、Renovaro Inc.、Immatics N V C/Wts 01/07/2025 ,振幅分别为194.07%、81.11%、70.39%。Vor Biopharma Inc.公司简介:Vor Biopharma Inc 是一家处于临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227042115a255441a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227042115a255441a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VOR","BK4139"],"gpt_icon":0},{"id":"2514801932","title":"Vor Biopharma Inc.盘中异动 早盘大幅下挫5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514801932","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514801932?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:00","pubTimestamp":1740499251,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时00分,Vor Biopharma Inc.股票出现异动,股价大幅下跌5.30%。截至发稿,该股报1.25美元/股,成交量11.8788万股,换手率0.10%,振幅6.06%。Vor Biopharma Inc.股票所在的生物技术行业中,整体涨幅为0.79%。其相关个股中,Organovo Holdings, Inc.、Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大,Organovo Holdings, Inc.、Gt Biopharma, Inc.、Silexion Therapeutics Corp较为活跃,换手率分别为1208.43%、1099.66%、767.55%,振幅较大的相关个股有Organovo Holdings, Inc.、Silexion Therapeutics Corp、Adial Pharmaceuticals, Inc,振幅分别为224.93%、87.83%、64.05%。Vor Biopharma Inc.公司简介:Vor Biopharma Inc 是一家处于临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226000051abdc93c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226000051abdc93c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VOR"],"gpt_icon":0},{"id":"2512616571","title":"Vor Biopharma Inc.盘中异动 股价大涨5.47%报1.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512616571","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512616571?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:50","pubTimestamp":1739890200,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时50分,Vor Biopharma Inc.股票出现波动,股价快速上涨5.47%。截至发稿,该股报1.45美元/股,成交量8.5405万股,换手率0.07%,振幅3.65%。Vor Biopharma Inc.股票所在的生物技术行业中,整体涨幅为0.97%。Vor Biopharma Inc.公司简介:Vor Biopharma Inc 是一家处于临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218225000988a00d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218225000988a00d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VOR"],"gpt_icon":0},{"id":"2511521510","title":"Vor Biopharma Inc.盘中异动 早盘大幅下跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511521510","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511521510?lang=zh_cn&edition=full","pubTime":"2025-02-13 23:00","pubTimestamp":1739458821,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日23时00分,Vor Biopharma Inc.股票出现波动,股价大幅下跌5.07%。截至发稿,该股报1.31美元/股,成交量5.8533万股,换手率0.05%,振幅7.97%。Vor Biopharma Inc.股票所在的生物技术行业中,整体涨幅为0.17%。其相关个股中,Edesa Biotech, Inc.、Enanta Pharmaceuticals, Inc.、Nutriband Inc C/Wts 涨幅较大,Edesa Biotech, Inc.、Tc Biopharm Plc、Genprex, Inc.较为活跃,换手率分别为1588.24%、1101.18%、121.07%,振幅较大的相关个股有天演药业、Immatics N V C/Wts 01/07/2025 、Edesa Biotech, Inc.,振幅分别为103.88%、92.30%、73.65%。Vor Biopharma Inc.公司简介:Vor Biopharma Inc 是一家处于临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021323002198843210&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021323002198843210&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VOR"],"gpt_icon":0},{"id":"2510339562","title":"Vor Biopharma Inc.盘中异动 股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510339562","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510339562?lang=zh_cn&edition=full","pubTime":"2025-02-11 23:40","pubTimestamp":1739288457,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日23时40分,Vor Biopharma Inc.股票出现波动,股价急速下跌5.07%。截至发稿,该股报1.31美元/股,成交量12.1656万股,换手率0.10%,振幅5.43%。Vor Biopharma Inc.股票所在的生物技术行业中,整体跌幅为1.74%。其相关个股中,Ocean Biomedical, Inc.、In8Bio, Inc.、Lipella Pharmaceuticals Inc.涨幅较大,Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃,换手率分别为2708.70%、1072.36%、373.67%,振幅较大的相关个股有Dominari Holdings Inc.、Ocean Biomedical, Inc.、In8Bio, Inc.,振幅分别为58.60%、57.43%、37.99%。Vor Biopharma Inc.公司简介:Vor Biopharma Inc 是一家处于临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211234057abcb1598&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211234057abcb1598&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VOR"],"gpt_icon":0},{"id":"2510866460","title":"Vor Biopharma Inc.盘中异动 早盘快速下挫6.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510866460","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510866460?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:35","pubTimestamp":1739198136,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时35分,Vor Biopharma Inc.股票出现波动,股价大幅下挫6.38%。Vor Biopharma Inc.股票所在的生物技术行业中,整体涨幅为0.23%。其相关个股中,60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Ocean Biomedical, Inc.、Nls Pharmaceutics Ltd.涨幅较大,Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.、Conduit Pharmaceuticals Inc.较为活跃,换手率分别为966.65%、628.56%、259.86%,振幅较大的相关个股有Invivyd, Inc.、Ocean Biomedical, Inc.、Nls Pharmaceutics Ltd.,振幅分别为29.90%、26.71%、22.45%。Vor Biopharma Inc.公司简介:Vor Biopharma Inc 是一家处于临床阶段的细胞治疗公司。公司的产品包括 VOR33。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223536abc9a65f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223536abc9a65f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VOR","BK4139"],"gpt_icon":0},{"id":"2509278487","title":"Vor Biopharma Inc.盘中异动 股价大跌6.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509278487","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509278487?lang=zh_cn&edition=full","pubTime":"2025-02-08 02:23","pubTimestamp":1738952587,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日02时23分,Vor Biopharma Inc.股票出现波动,股价大幅下跌6.00%。截至发稿,该股报1.41美元/股,成交量29.2936万股,换手率0.23%,振幅8.00%。Vor Biopharma Inc.股票所在的生物技术行业中,整体跌幅为0.55%。Vor Biopharma Inc.公司简介:Vor Biopharma Inc 是一家处于临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208022307a23d5473&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208022307a23d5473&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VOR","BK4139"],"gpt_icon":0},{"id":"2509231764","title":"Vor Biopharma Inc.盘中异动 临近午盘急速拉升5.40%报1.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509231764","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509231764?lang=zh_cn&edition=full","pubTime":"2025-02-06 00:39","pubTimestamp":1738773563,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日00时39分,Vor Biopharma Inc.股票出现异动,股价急速拉升5.40%。截至发稿,该股报1.47美元/股,成交量18.259万股,换手率0.15%,振幅7.86%。Vor Biopharma Inc.股票所在的生物技术行业中,整体涨幅为1.33%。其相关个股中,Oragenics Inc.、Transcode Therapeutics, Inc.、Pasithea Therapeutics Corp.涨幅较大,Pasithea Therapeutics Corp.、Transcode Therapeutics, Inc.、Oragenics Inc.较为活跃,换手率分别为4334.48%、1964.10%、1335.90%,振幅较大的相关个股有Transcode Therapeutics, Inc.、Oragenics Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028,振幅分别为99.51%、59.80%、54.05%。Vor Biopharma Inc.公司简介:Vor Biopharma Inc 是一家处于临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206003923987b917f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206003923987b917f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VOR"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vorbio.com","stockEarnings":[{"period":"1week","weight":0.1395},{"period":"1month","weight":0.1237},{"period":"3month","weight":0.8535},{"period":"6month","weight":-0.6081},{"period":"1year","weight":-0.3045},{"period":"ytd","weight":0.1804}],"compareEarnings":[{"period":"1week","weight":-0.005},{"period":"1month","weight":-0.0136},{"period":"3month","weight":0.0038},{"period":"6month","weight":0.0635},{"period":"1year","weight":0.1725},{"period":"ytd","weight":0.006}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Vor Biopharma Inc.于2015年12月30日在特拉华州注册成立为PureTech Health LLC的全资子公司。该公司是一家临床阶段的细胞疗法公司,结合了新颖的患者工程方法和靶向疗法,为患有血液系统恶性肿瘤的患者提供了单一的公司解决方案。该公司的专有平台利用其在造血干细胞生物学,基因组工程和靶向疗法开发方面的专业知识,对HSC进行基因修饰,以去除癌细胞表达的表面靶标。Vor总部位于马萨诸塞州剑桥。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.04043},{"month":2,"riseRate":0.6,"avgChangeRate":0.020325},{"month":3,"riseRate":0.2,"avgChangeRate":-0.142709},{"month":4,"riseRate":0,"avgChangeRate":-0.179628},{"month":5,"riseRate":0.2,"avgChangeRate":-0.276218},{"month":6,"riseRate":0.4,"avgChangeRate":1.31333},{"month":7,"riseRate":0.2,"avgChangeRate":-0.043439},{"month":8,"riseRate":0.4,"avgChangeRate":0.001368},{"month":9,"riseRate":0.4,"avgChangeRate":-0.0543},{"month":10,"riseRate":0.6,"avgChangeRate":-0.046096},{"month":11,"riseRate":0.2,"avgChangeRate":-0.192554},{"month":12,"riseRate":1,"avgChangeRate":0.3146}],"exchange":"NASDAQ","name":"Vor Biopharma Inc.","nameEN":"Vor Biopharma Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Vor Biopharma Inc.(VOR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Vor Biopharma Inc.(VOR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Vor Biopharma Inc.,VOR,Vor Biopharma Inc.股票,Vor Biopharma Inc.股票老虎,Vor Biopharma Inc.股票老虎国际,Vor Biopharma Inc.行情,Vor Biopharma Inc.股票行情,Vor Biopharma Inc.股价,Vor Biopharma Inc.股市,Vor Biopharma Inc.股票价格,Vor Biopharma Inc.股票交易,Vor Biopharma Inc.股票购买,Vor Biopharma Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Vor Biopharma Inc.(VOR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Vor Biopharma Inc.(VOR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}